High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancerMarina N. Sharifi, Martin Sjöström, Eric Feng et al.|Molecular Oncology|2025Cited by 4
Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancerJamie M. Sperger, Joshua M. Lang, Marina N. Sharifi et al.|Cancer Research|2024Cited by 1
Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancerMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Clinical Cancer Research|2024Cited by 0
Author response for "Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer"Marina N. Sharifi, Martin Sjöström, Eric Feng et al.|Unknown|2024Cited by 0